Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,612,700 | 886,900 | 1,092,900 | 1,724,000 | 7,554,700 |
| Marketable Securities | 3,829,100 | 4,939,000 | 7,858,200 | 11,501,500 | 19,837,600 |
| Receivables | 2,808,600 | 2,795,900 | 2,542,000 | 2,531,000 | 2,398,500 |
| Inventories | 899,800 | 935,900 | 904,700 | 718,000 | 705,500 |
| Other current assets | 0 | 0 | 0 | 0 | 455,900 |
| TOTAL | $10,112,800 | $10,433,200 | $13,700,700 | $17,857,900 | $31,723,900 |
| Non-Current Assets | |||||
| PPE Net | 1,802,200 | 1,750,100 | 1,659,300 | 1,611,300 | 1,566,300 |
| Investments And Advances | 269,900 | 290,200 | 283,200 | 282,100 | 341,100 |
| Intangibles | 106,469,800 | 111,961,900 | 110,911,300 | 108,974,700 | 109,648,500 |
| Other Non-Current Assets | 338,100 | 299,400 | 282,400 | 260,300 | 327,900 |
| TOTAL | $108,880,000 | $114,301,600 | $113,136,200 | $111,128,400 | $111,883,800 |
| Total Assets | $118,992,800 | $124,734,800 | $126,836,900 | $128,986,300 | $143,607,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,591,800 |
| Accounts payable and accrued liabilities | 4,541,700 | 4,684,600 | 4,795,400 | 5,019,000 | 5,425,400 |
| Other current liabilities | 3,797,000 | 3,795,000 | 5,526,400 | 2,797,900 | 223,700 |
| TOTAL | $8,559,800 | $8,638,300 | $10,391,600 | $7,874,700 | $8,025,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,539,100 | 26,443,300 | 26,223,000 | 29,970,800 | 31,178,200 |
| Other Non-Current Liabilities | 1,916,700 | 1,932,400 | 1,974,000 | 1,969,400 | 1,860,300 |
| TOTAL | $39,259,500 | $40,863,700 | $41,246,500 | $44,911,100 | $45,851,800 |
| Total Liabilities | $47,819,300 | $49,502,000 | $51,638,100 | $52,785,800 | $53,877,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 332,583 | 334,306 | 335,867 | 335,225 | 375,080 |
| Retained earnings | 10,137,200 | 14,397,900 | 15,429,900 | 18,342,500 | 18,412,700 |
| Other shareholders' equity | 1,725,300 | 1,637,400 | 732,100 | -1,030,600 | 603,800 |
| TOTAL | $71,173,500 | $75,232,800 | $75,198,800 | $76,200,500 | $89,730,400 |
| Total Liabilities And Equity | $118,992,800 | $124,734,800 | $126,836,900 | $128,986,300 | $143,607,700 |